Rotavirus Vaccine Contraindicated for SCID Infants
- By BSTQ Staff
According to the Centers for Disease Control and Prevention, the rotavirus vaccine is now contraindicated for infants diagnosed with severe combined immunodeficiency (SCID), and the organization is updating its contraindications list. This is in response to reported cases of vaccine-acquired rotavirus infection in infants with SCID following rotavirus vaccine administration. Merck & Co. and GlaxoSmithKline Biologics have revised their prescribing information and patient labeling for their respective rotavirus vaccine products, pentavalent rotavirus vaccine (RV5) and monovalent rotavirus vaccine (RV1), with approval from the U.S. Food and Drug Administration.